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Abstract  
Introduction: We present the first longitudinal study in Poland analysing the association 
between fat mass and obesity-associated gene (FTO) polymorphism and changes in 
anthropometric parameters.  
Material and methods: 1120 participants of the Prospective Urban Rural (PURE) study in 
Poland (mean age 53.7 years) were genotyped for FTO gene polymorphism (rs9939609, 
rs9930506, rs1421085, rs1121980). Anthropometric parameters were measured at three time 
points (baseline, after three years, and after six years of observation).  
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Results: The mean body mass index (BMI) in the study group was 28 kg/m2. Overall, there 
was a significant increase in the mean weight, BMI, and waist size during the six years (p ≈ 0). 
Although males initially weighed more than females (p = 0), over the whole six-year period 
women had a greater tendency to increase in weight (p = 0.068), BMI (p = 0.014), and waist 
size (p = 0.041). Subjects with at least one A allele at rs9939609 initially weighed more on 
average (77.5 kg vs. 74.7 kg, p = 0.027) and had a greater waist size (92 cm vs. 89.5 cm, p = 
0.025) than those with the TT genotype. The differences in baseline results were more expressed 
in males than in females. There is no association between the changes in anthropometric 
parameters over the whole study period of six years and the FTO gene. 
Conclusions: FTO gene polymorphism is associated with anthropometric parameters in 
participants from the PURE study in Poland. However, there is no association between the 
presence of risk alleles and changes of anthropometric parameters over six years of observation. 
Key words: FTO gene; polymorphism; obesity; weight gain; longitudinal study 
 
Introduction 
Obesity has become a major health problem worldwide. Globally, the proportion of 
adults with a body mass index (BMI) of over 25 has risen from 28.8% to 36.9% in men and 
from 29.8 to 38.0% in women in the years 1980–2013 [1].  
Genome-wide association studies (GWAS) have identified many common gene variants 
associated with obesity. One of them is the fat mass and obesity-associated gene (FTO), located 
in chromosome region 16q12.2. FTO encodes nucleic acid demethylase, a protein regulating 
gene expression by the internal modification of messenger RNA (mRNA) [2]. It is highly 
expressed in regions critical for controlling the energy balance. It has been shown that FTO risk 
alleles are associated with increased food intake, a preference for high-calorie products and 
diminished satiety after meals [3–5]. There is also evidence of FTO-specific differences in brain 
structure and function, as well as in the visual perception of food [6].  
The FTO polymorphism is suggested to be the strongest genetic determinant of common 
obesity [7], also predisposing to extreme obesity [8]. However, this is mostly based on cross-
sectional data [7–9]. A few longitudinal studies [10, 11] have shown that FTO risk variants 
predispose individuals to weight gain from childhood until early adulthood, where further 
weight gain may occur. Most studies suggest that the effect of FTO becomes evident after the 
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age of seven years [10, 12], strengthening throughout childhood up to the age of 20 years, and 
then weakening with increasing age [13]. 
The frequency of obesity in Poland is rising. According to The Multicentre National 
Population Health Examination Survey (WOBASZ), the frequency of obesity rose from 22.3% 
to 23.4% in women, and from 20% to 24.2% in men, over 10 years of observation [14]. The 
aim of our study is to evaluate whether the FTO polymorphism is associated with changes in 
anthropometric parameters over a period of six years of observation based on data from the 
Prospective Urban Rural Study (PURE) carried out in Poland.  
 
Material and methods 
Study group and examination protocol 
Our analysis was carried out on the basis of data from participants of the PURE Study from 
Lower Silesia in Poland, whose FTO gene had been sequenced (initially 1120 subjects). During 
follow-up, 716 participants were observed at three time points (baseline — 2007, after three 
years, and after six years). The design of the PURE Study has been described previously [15]. 
Each participant gave oral and written consent. The study was approved by Wroclaw Medical 
University Ethical Committee (KB 438/2014).   
All participants were examined at each time point, including the measurement of height 
(accuracy of 0.5 cm) and weight (accuracy of 0.1 kg). On this basis the body mass index (BMI) 
was calculated: BMI = weight (kg)/[height (m)]2.  
Anthropometric measurements included the waist circumference (halfway between the lowest 
rib and the top of the hipbone) and the hip circumference (at the widest part of the buttocks).  
Genotyping 
Each participant was genotyped for four FTO gene variants (rs9939609, rs9930506, rs1421085, 
and rs1121980). Simultaneous identification of all these single nucleotide polymorphisms 
(SNPs) was conducted using the mini-sequencing method with a pair of designed specific 
primers. This method was described precisely in a previous publication [16]. 
 
Statistical analysis 
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In order to compare the distribution of the genotypes with the Hardy-Weinberg equilibrium, the 
frequencies of the alleles in the sample were calculated using gene counting, and then the 
standard chi-squared goodness-of-fit test was used. The R2 measure was used to assess the 
strength of linkage disequilibrium between two loci, where R is the Pearson coefficient of 
correlation between the numbers of risk alleles at these loci. Due to the large sample size, the 
t-test for paired samples was used to test whether the mean BMI or weight had changed over 
the study period (in the population as a whole and amongst those of a given sex). The t-test for 
independent samples was used to test whether there existed an association of the initial BMI, 
initial weight, the change in BMI over the study period, and the change in weight over the study 
period with sex.  
Three models of genetic dominance were used to investigate the relation between genotype and 
BMI. Model I assumed that the risk allele dominated the non-risk allele. Under this model, the 
t-test for independent samples was applied to test if the BMI and weight (as well as the changes 
in these variables) varied according to whether an individual carried at least one risk allele or 
not. Model II assumed that the non-risk allele dominated the risk allele. Under this model, the 
t-test for independent samples was applied to test if the BMI and weight (as well as the changes 
in these variables) varied according to whether an individual carried at least one non-risk allele 
or not. Model III assumed that there was no dominance relationship between the risk and non-
risk alleles. Under this model, analysis of variance was applied to test whether BMI and weight 
(as well as the changes in these variables) varied according to the genotype of an individual.  
 
Results 
We collected data from 457 (63.83%) females and 257 (36.17%) males. It is assumed that the 
missing subjects from the two later sets of observations were missing completely at random, 
i.e. there was no association between any of the variables and whether individuals were 
observed at later time points. The mean initial age was 53.7 with a standard deviation of 7.05 
and a range between 32 and 74 years. 
Comparison with the Hardy-Weinberg equilibrium 
There was no significant deviation from the Hardy-Weinberg equilibrium at any of the four loci 
(Tab. 1, 2). 
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Table 1. Comparison with the Hardy-Weinberg equilibrium for FTO polymorphism rs1121980 
and rs1421085 
rs1121980 rs1421085 
 Observed Expected  Observed Expected 
CC 215 (30%) 216.3 (30.2%) CC 142 (19.8%) 137.7 (19.2%) 
CT 357 (49.9%) 354.5 (49.5%) CT 344 (48%) 352.6 (49.2%) 
TT 144 (20.1%) 145.3 (20.3%) TT 230 (32.2%) 225.7 (31.6%) 
n 716  n 711  
p 0.85  p 0.51  
 
Table 2. Comparison with the Hardy-Weinberg equilibrium for FTO polymorphism rs9930506 
and rs9939609 
rs9930506 rs9939609 
 Observed Expected  Observed Expected 
AA 207 (29.1%) 208.5 (29.3%) AA 135 (19%) 131.7 (18.5%) 
AG 356 (50.1%) 353 (49.7%) CT 342 (48.1%) 348.6 (49%) 
GG 148 (20.8%) 149.5 (21%) TT 234 (32.9%) 230.7 (32.5%) 
n 711  n 711  
p 0.82  p 0.61  
 
Analysis of linkage disequilibrium between pairs of loci 
There was very strong linkage disequilibrium between all the studied loci; the minimum R2 
value is 0.7681 (Tab. 3). The most common haplotypes (presented in the order rs1121980-
rs1421085-rs9930506-rs9939609) are CTAT and TCGA. 
Due to this very strong linkage disequilibrium, further analysis was based purely on the 
genotype at the rs9939609 locus. 
Table 3. Measures of linkage disequilibrium between pairs of loci 
 rs9939609 rs9930506 rs1421085 
rs1121980 R2 =  
0.8297 
R2 = 0.8177 R2 = 0.9252 
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rs1421085 R2 = 
0.8574 
R2 = 0.7681  
rs9930506 R2 = 
0.8537 
  
R — Pearson coefficient of correlation; R2 – measure of linkage disequilibrium 
 
Changes in body mass and waist measurements 
The results of anthropometric parameters measurements are presented in Table 4. The mean 
BMI in the study group was 28 kg/m2. Almost 30% of the participants were obese according to 
the definition of having BMI over 30 kg/m2 (208 out of 716). There was no association between 
sex and obesity. 291 out of 716 participants (40.6%) were classified as being overweight (BMI 
25-29.9 kg/m2). Males were significantly more likely than females to be classified as 
overweight (123 out of 257 males, 47.9%, and 168 out of 457 females, 36.8%, p = 0.004). Close 
to 40% of the participants (284 out of 716) were classified as obese on the basis of the waist 
circumference criterion (over 88 cm in females and 102 cm in males). Females were more likely 
to be classified as obese according to this criterion (208 out of 457 females, 45.5%, and 76 out 
of 257 males, 29.6%, p = 0.00003). 
Overall, there was a significant increase in the mean weight and BMI over the full period of six 
years (t = 4.95, p ≈ 0 and t = 5.70, p ≈ 0, respectively). There was a significant increase in 
waist size (both in the course of three years and in the course of six years, t = 3.12, p = 0.0018 
and t = 6.21, p  ≈ 0, respectively). There was a significant decrease in hip size (both in the 
course of three years and in the course of six years, t = 6.35, p ≈ 0 and t = 3.04, p = 0.0025, 
respectively). Although males initially weighed more than females (t = 10.61, p = 0), over the 
whole six-year period women showed a greater tendency to increase in weight (p = 0.068), BMI 
(p = 0.014), and waist size (p = 0.041). The fall in hip size over the first three years is greater 
among females than among males (p = 0.035). 
Table 4. Changes in anthropometric parameters of the participants in the course of the study 
(standard deviation given in brackets) 
 Initially After 3 years After 6 years 
Weight [kg] 
Whole group 
 
76.6 (16.1) 
 
76.7 (16.3) 
 
77.7 (16.6) 
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Males 
Females 
84.6 (15.6) 
72.0 (14.6) 
84.7 (15.8) 
72.2 (14.8) 
85.2 (15.8) 
73.4 (15.6) 
BMI [kg/m2] 
Whole group 
Males 
Females 
 
28.0 (5.2) 
28.4 (4.7) 
27.8 (5.4) 
 
28.1 (5.1) 
28.4 (4.6) 
27.9 (5.4) 
 
28.5 (5.4) 
28.6 (4.6) 
28.5 (5.8) 
Waist [cm] 
Whole group 
Males 
Females 
 
91.1 (14.0) 
97.2 (12.4) 
87.7 (13.7) 
 
91.8 (14.1) 
97.7 (12.2) 
88.5 (14.0) 
 
93 (15) 
97.9 (13.8) 
90.1 (15) 
Hips [cm] 
Whole group 
Males 
Females 
 
104 (9.9) 
102.7 (8.7) 
104.7 (10.5) 
 
102.8 (9.8) 
102.1 (8.9) 
103.3 (10.2) 
 
103 (11.7) 
101.9 (11.2) 
103.7 (11.9) 
 
The FTO polymorphism and anthropometric parameters 
The mean change in the anthropometric parameters according to FTO polymorphism are 
presented in Table 5.  
Subjects with at least one A allele at rs9939609 initially weighed more on average than those 
with the TT genotype (77.5 kg vs. 74.7 kg, p = 0.027), although the analogous difference 
between mean BMIs was not significant (28.3 vs. 27.5, p = 0.069). 
Those with at least one A allele at rs9939609 initially had a greater waist size than those with 
the TT genotype (92 cm vs. 89.5 cm, p = 0.025). 
Those with at least one A allele at rs9939609 initially had a greater hip size than those with the 
TT genotype (104.5 cm vs. 102.8 cm, p = 0.030). 
The anthropometric parameters were also analysed for males and females separately. Males 
with at least one A allele weighed more (85.9 vs. 81.6, p = 0.022) and had a higher average 
BMI (28.8 vs. 27.4, p = 0.015) initially than those with genotype TT, while there was no 
association between the FTO genotype and body parameters among females. 
There was no association between the changes in weight or BMI over the whole study period 
of six years and the genotype at FTO rs9939609 based on a model that assumes no dominance 
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relation between the alleles (p = 0.424, p = 0.46, respectively). There was also no association 
between the changes in waist or hip size over the whole study period and the FTO 
polymorphism (p = 0.565, p = 0.718, respectively). Similar results were obtained on the basis 
of models that assumed one of the alleles dominated the other.  
Table 5. Changes in anthropometric parameters according to the FTO polymorphism (standard 
deviation given in brackets) 
 Initially After 3 years After 6 years 
Weight [kg]    
AA 77.2 (16.5) 77.9 (17.4) 78.4 (17.7) 
AT 77.6 (16.8) 77.6 (16.7) 78.4 (17.0) 
TT 74.7 (14.7) 74.9 (15.0) 76.2 (15.4) 
BMI [kg/m2]    
AA 28.3 (5.6) 28.6 (5.7) 28.9 (6.0) 
AT 28.2 (5.1) 28.2 (4.9) 28.6 (5.2) 
TT 27.5 (5.0) 27.5 (5.1) 28.2 (5.2) 
Waist [cm]    
AA 92.1 (15.4) 93.7 (16.2) 94.1 (16.4) 
AT 91.9 (13.8) 92.4 (13.6) 93.3 (15.1) 
TT 89.5 (13.5) 89.9 (13.3) 91.7 (14.2) 
Hip [cm]    
AA 104.8 (10.3) 104.4 (10.5) 104.3 (11.6) 
AT 104.4 (9.9) 103.1 (9.5) 103.3 (11.5) 
TT 102.8 (9.7) 101.6 (9.6) 101.9 (11.9) 
BMI — body mass index 
 
Discussion 
In this study, we analysed the association between variants of the FTO gene and changes in 
anthropometric parameters in a group of 716 subjects from the PURE study in Poland over a 
study period of six years. We examined four FTO polymorphisms (rs9939609, rs9930506, 
rs1421085, rs1121980) and found very strong linkage disequilibrium between all these loci. 
This is in accordance with the findings of Sobalska-Kwapis et al., who genotyped 5418 Polish 
adults and found that rs9939609 was in very high linkage disequilibrium with all the SNPs in 
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block 8 and with a number of SNPs from blocks 3 to 7 [17]. Therefore, our further analysis was 
based on loci rs9939609.  
It was found that the most common haplotypes (given in the order rs1121980- rs1421085- 
rs9930506- rs9939609) were CTAT (all protective alleles) and TCGA (all risk alleles) — so-
called “yin-yang” haplotypes. These haplotypes comprised over 90% of FTO variants in a more 
homogenous Polish cohort (854 non-obese individuals) that had been genotyped previously 
[16]. Together with our current results, this confirms that the Polish population is genetically 
rather homogenous and characterised by two disparate FTO haplotypes with strong linkage 
disequilibrium between the FTO loci in intron 1. 
The mean initial BMI in our group (28 kg/m2) was indicative that a large proportion of the 
sample were overweight, and we also observed a high initial mean waist size (91.1 cm). Both 
of these parameters increased significantly during the six years of follow-up (p ≈ 0). This is in 
accordance with the global trend of an increasing frequency of obesity [1] and with other Polish 
studies. During 10 years of observation, the distribution of BMI in the Polish WOBASZ 
population shifted to higher values, particularly in men [14]. However, in our group, women 
showed a more significant increase in BMI and waist circumference in comparison to men. This 
difference remains unclear. The determinants of obesity in our baseline cohort have been 
previously analysed [18]. It was found that environmental and socioeconomic factors, such as 
rural inhabitancy, unemployment, and stress, were significantly associated with obesity, 
especially in women, while genetic factors played a more important role in males. Probably, 
the environmental determinants of obesity become stronger with time, while genetic 
predisposition to obesity becomes weaker in older age. Another reason for the greater weight 
gain in women might be hormonal status. The mean age of females in our group (54.3 years) is 
often associated with hormonal changes due to menopause. Decreases in the oestrogen level 
may predispose women to fat accumulation in this period. A significant decrease in hip size 
was observed in our study, greater amongst females than amongst males. Together with an 
increase in waist size, this is typical of a change from gynoid to android obesity. Such changes 
are characteristic during the menopausal period, due to decreasing levels of oestrogen. 
Few longitudinal studies have analysed the association between the FTO genotype and weight 
gain. This influence was first discovered in children, where FTO-mediated predisposition to 
obesity becomes stronger between the ages 4 and 11 years [19]. In a cohort of 1629 Danish 
men, Jess et al. found that carriers of risk allele were predisposed to weight gain in two periods: 
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from birth to seven years of age and later from adolescence to early adulthood. The mean weight 
excess in risk allele homozygotes was estimated at 7 kg at the age of 20 years and 18 kg at the 
age of 46 years, compared to non-risk allele homozygotes [10]. However, the assessment of 
males alone appears to be an important limitation of this study. Similarly, in adolescents from 
the HUNT study, the FTO polymorphism was associated with becoming overweight in 
adulthood [11]. In another longitudinal study, Hardy et al. reported that the association between 
the FTO gene and BMI strengthened from childhood to adolescence, reached its maximal 
influence at the age of 20 years, and weakened during later life (observations were made up to 
the age of 53 years) [13]. Qi et al. also stated that the influence of FTO is weaker in older age 
[20]. We found that the FTO polymorphism is associated with initial weight, BMI, and waist 
and hip size. This influence is stronger in males — men with at least one A allele on average 
weigh more (85.9 vs. 81.6, p = 0.022) and have higher BMI (28.8 vs. 27.4, p = 0.015) initially 
than those with genotype TT. No such associations were found in females. The reasons for these 
sex-dependent differences in the influence of FTO on body mass parameters are discussed in 
our other publication [21]. However, the current study indicates that FTO risk alleles have no 
significant influence on weight gain in our study group over the six-year study period. Probably, 
the older age of our participants, in comparison to the aforementioned studies, blurs the effect 
of genetic predisposition to obesity. We suppose that environmental factors play a greater role 
in weight gain within this age group. Another possible reason for this negative result might be 
the relatively short period of observation. 
To our knowledge, this is the first longitudinal study in Poland analysing the association 
between the FTO gene and changes in anthropometric parameters. Previously, Polish studies 
had only a cross-sectional character. Recently, in a group of 5418 Polish adults it was found 
that FTO variation was related to BMI. Similarly to our results, the FTO gene predisposes only 
males to becoming overweight [17]. Other Polish studies were based on smaller groups of 
subjects.  
We believe that it is important to report negative results, because they create a full picture of 
the problem studied. Our study has some limitations. Of the initial 1120 subjects, 711 were 
observed during follow-up (both after three years and after six years). However, due to the 
relatively young age of the majority of these participants, it seems to be a reasonable assumption 
that those subjects who were not observed during follow-up were missing completely at 
random, and the number of participants remains large. Another strength of this study was that 
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anthropometric and clinical measurements were carried by trained personnel, thus avoiding the 
pitfall of under- or mis-reporting weight-related measures. 
 
Conclusions 
In conclusion, we have found that the FTO gene polymorphism is associated with body mass 
in males from the PURE study in Poland. However, there is no association between the presence 
of risk alleles and weight change over six years. 
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